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The giant sarcomere protein titin bears passive load in cardiomyocytes (CMs)
and altered titin stiffness occurs in heart failure. Contributions to CMs stiff-
ness may also come from the actin and microtubular networks. Our aim was
to quantify the contribution of titin to CMs viscoelasticity through specific
cleavage of the titin springs in situ. We have developed a knock-in (KI)
mouse model carrying a tobacco etch virus (TEV) protease-recognition site
and a HaloTag in titin’s elastic region. This HaloTag-TEV cassette allows
for specific titin cleavage during mechanical measurements of CMs and visu-
alization of successful cleavage. TEV-protease induced a complete, rapid,
and specific cleavage of cardiac titin in skinned homozygous KI CMs, but
not in wildtype. Confocal and atomic force microscopy were combined to
quantify the transversal stiffness of CMs by nanoindentation. The Young’s
modulus of homozygous KI cells at a pre-set force of 3 nN was significantly
reduced with titin-cleavage, by 2654% (n= 26 cells), indicating cell soft-
ening. The amplitude of this decrease was similar to that found in nanoinden-
tation measurements on human CMs upon microtubule depolymerisation
(Chen et al, Nat Med 2018;24:1225-1233). Furthermore, skinned KI CMs
were stretched within physiological sarcomere lengths and the passive force
recorded before and after TEV-treatment. TEV-protease reduced the steady-
state force by 5358% and the viscous force by 5657% (n=9 cells). The
skinned KI CMs were also incubated first with an actin-severing, Ca2þ-inde-
pendent gelsolin fragment and then with TEV-protease, which reduced the
passive force to 82% and 27% of the value before treatment, respectively
(n=6 cells). Thus, titin is the main contributor to tensile force but the actin
cytoskeleton contributes as well. High mechanical connectivity between
the cytoskeletal elements is likely to occur in CMs, implicating a tensegrity
structure.29-Plat
BAG3 Localizes to the Mature Sarcomere and Maintains Myofilament
Function
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Bcl-2-associated athanogene 3 (BAG3) is a co-chaperone canonically
involved in protein quality control (PQC). Decreased levels and mutations
to BAG3 are linked with heart failure, though the mechanisms remain un-
clear. Neonatal myocyte studies showed BAG3 localizes to the Z-disk, how-
ever, the functional role of BAG3 at the sarcomere is unknown. First, we
confirmed BAG3 co-localization with Z-disk a-actinin in the mature myofil-
ament using immunofluorescence in human left ventricular (LV) cardiomyo-
cytes. Furthermore, by western blot this myofilament-fraction of BAG3
decreased by 20% in human heart failure. To test the hypothesis that
decreased myofilament-bound BAG3 is detrimental to function, we used a
mouse model of myocardial infarction (MI)-induced heart failure. Eight
weeks post-MI, BAG3 was overexpressed via associated adenovirus-9 for
three weeks. Myofilament function was assessed in LV cardiomyocytes.
Compared with sham, MI decreased maximal calcium-induced force
(Fmax). However, BAG3 overexpression restored Fmax to sham levels. To
explore the mechanism responsible, we identified BAG3’s myofilament inter-
actome using immunoprecipitation and mass spectrometry. Interestingly,
Hsp70 and HspB8, which together with BAG3 promote PQC in other cell
types, were among the top hits. Association of this complex with the myofil-
ament was confirmed by co-immunoprecipitation and immunofluorescence
showing colocalization of HspB8 and Hsp70 at the Z-disk, suggesting a
role for the complex in myofilament PQC. To support the functional signif-
icance of this complex, myofilament function was assessed in mice express-
ing the BAG3 P209L mutant, previously shown to impair client processing
by the BAG3-Hsp complex. P209L mice displayed age-dependent depression
of myofilament function. This work is the first to show BAG3 localizes to the
mature sarcomere and modulates myofilament function in cardiomyocytes,
which is disrupted by MI and mutation. Additionally, our data suggests
that the maintenance of function following cardiac stress may be due to
myofilament PQC.30-Plat
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Mavacamten (MYK-461, Axon Medchem BV ) is an allosteric inhibitor of sar-
comeric myosins presently used in preclinical/clinical trials for HCM treatment
(Anderson et al., 2018)). Here, single or thin bundles of myofibrils from rabbit
fast skeletal muscle (psoas) and human donor ventricle (frozen samples) have
been used to study the effects of mmolar Mavacamten on maximal isometric
force. Both myofibril types were mounted in relaxing solution (pCa 9; [Pi] 
200 mM , 15 C,) and then fully activated (pCa 4.5) with and without selected
concentrations of Mavacamten or subjected to rapid Mavacamten jumps in acti-
vating solution. Dose-response curves confirmed a higher sensitivity of
maximal isometric force developed by cardiac muscle (IC50 0.5 mM)
compared to fast skeletal (IC5010 mM) as previously reported for pCa50- acti-
vated ATPase of the same myofibrillar systems (Kawas et al., 2017). In fast
skeletal myofibrils, the kinetics of force development were also strongly
depressed by Mavacamten with a trend to a higher sensitivity compared to
the effect on tension. This effect was undetectable in human ventricle. When
submitted to Mavacamten jumps, both myofibril types responded with a rapid
relaxation-like force drop (fully reversible ) whose sensitivity to Mavacamten
concentration was the same as that of the kinetics of force relaxation measured
in the same conditions. The effect was unaffected by ADP (10 mM) and Pi (0-1
mM range). The results obtained are in agreement with the reported effect of
Mavacamten on multiple stages of cross-bridge chemo-mechanical cycle (i.e.
inhibition of Pi release rate and decrease of actin binding in M.ADP states)
as well as on regulation state mediated by the availability of strongly actin bind-
ing heads. SilicoFCM EU H2020 grant agreement n. 777204.31-Plat
FRET Measurements of the Power Stroke in Human Cardiac Myosin
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We used a FRET strategy to investigate structural changes in the lever arm
domain of human beta cardiac myosin subfragment 1 (M2B-S1). We
exchanged Alexa488 labeled human ventricular regulatory light chain
(V105C) onto M2B-S1 (M2B-S1 A.RLC) which served as a donor for Cy3ATP
bound to the active site. The functional properties (ATPase and in vitro
motility) of M2B-S1 A.RLC were similar to WT. The FRET efficiency was
2-fold higher in the presence of Cy3ATP compared to Cy3ADP. We monitored
the FRET signal during the actin-activated product release steps using transient
kinetic measurements. At lower actin concentrations the main component of the
FRET transients was dependent on actin concentration and similar to the
ATPase cycle time. At higher actin concentrations we observed a fast phase
(8-10 s1 at 30 mM actin) and a slower phase (2-3 s1 at 30 mM actin) that
was similar to the steady-state ATPase rate. Measurements as a function of tem-
perature revealed that the slower phase was similar to the steady-state ATPase
rate while the fast phase was 2-3 fold faster. We propose that the fast phase
measured with our FRET probes represents the structural change associated
with movement of the lever arm during the power stroke. We also performed
measurements in the presence of the heart failure drug Omecamtiv Mercarbil
which is proposed to inhibit the power stroke. We observed a lag in the fluores-
cence transients followed by a fluorescence change that was similar to the over-
all ATPase rate, suggesting little movement of the lever arm during actin-
activated phosphate release. Our FRET approach can be utilized to examine
the impact of disease mutations on the conformation of the lever arm in human
cardiac myosin which will be crucial for establishing structure-based mecha-
nisms of contractile dysfunction.32-Plat
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Thin filament-linked proteins actin, tropomyosin, and troponin are the major
regulators of cardiac and skeletal muscle that activate contraction through
calcium-mediated conformational changes. Single point mutations within the
